- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 459-473 of
1,261 results
1068 Exhibit: 1068 US Patent No 8,129,343
Document
IPR2024-00631, No. 1068 Exhibit - 1068 US Patent No 8,129,343 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1039 Exhibit: 1039 Victoza, PHYSICIANS’ DESK REFERENCE 65th ed 2010
Document
IPR2024-00631, No. 1039 Exhibit - 1039 Victoza, PHYSICIANS’ DESK REFERENCE 65th ed 2010 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1031 Exhibit: 1031 Knudsen, GLP1 Derivatives as Novel Compounds for the Treat...
Document
IPR2024-00631, No. 1031 Exhibit - 1031 Knudsen, GLP1 Derivatives as Novel Compounds for the Treatment of Typ (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
2006 Exhibit: EX2006 Excerpted Declaration of Robin S Goland, MD, Mylan Pharm...
Document
IPR2024-00631, No. 2006 Exhibit - EX2006 Excerpted Declaration of Robin S Goland, MD, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, EX2054 (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
2002 Exhibit: EX2002 Joint Stipulation to Modify Due Dates 2, 3, 4, 5, 6, 7 and 8, M...
Document
IPR2024-00631, No. 2002 Exhibit - EX2002 Joint Stipulation to Modify Due Dates 2, 3, 4, 5, 6, 7 and 8, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724 Paper 47 (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
2004 Exhibit: EX2004 Excerpted Patent Owner’s Response, Mylan Pharms Inc v N...
Document
IPR2024-00631, No. 2004 Exhibit - EX2004 Excerpted Patent Owner’s Response, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, Paper 30 (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
2007 Exhibit: EX2007 Excerpted Declaration of Michael J Blaha, MD, Mylan Pharm...
Document
IPR2024-00631, No. 2007 Exhibit - EX2007 Excerpted Declaration of Michael J Blaha, MD, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, EX2055 (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
2012 Exhibit: EX2012 Declaration of Sayem Osman
Document
IPR2024-00631, No. 2012 Exhibit - EX2012 Declaration of Sayem Osman (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
2001 Exhibit: EX2001 Docket Sheet from PTACTS, Mylan Pharms Inc v Novo Nordi...
Document
IPR2024-00631, No. 2001 Exhibit - EX2001 Docket Sheet from PTACTS, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724 (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
2005 Exhibit: EX2005 Excerpted Declaration of George L Bakris, MD, Mylan Pharm...
Document
IPR2024-00631, No. 2005 Exhibit - EX2005 Excerpted Declaration of George L Bakris, MD, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, EX2011 (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
2009 Exhibit: EX2009 Excerpted Declaration of Patrick J Sinko, PhD, Mylan Pharm...
Document
IPR2024-00631, No. 2009 Exhibit - EX2009 Excerpted Declaration of Patrick J Sinko, PhD, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, EX2056 (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
1002 Exhibit: 1002 Prosecution history excerpts for US Patent No 10,335,462
Document
IPR2024-00631, No. 1002 Exhibit - 1002 Prosecution history excerpts for US Patent No 10,335,462 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1503 Exhibit: 1503 Declaration of Mark J Ratain, MD
Document
IPR2024-00631, No. 1503 Exhibit - 1503 Declaration of Mark J Ratain, MD (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1051 Exhibit: 1051 Landersdorfer, PharmacokineticPharmacodynamic Modelling in...
Document
IPR2024-00631, No. 1051 Exhibit - 1051 Landersdorfer, PharmacokineticPharmacodynamic Modelling in Diabetes M (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1078 Exhibit: 1078 US Patent App Pub No 20040102486
Document
IPR2024-00631, No. 1078 Exhibit - 1078 US Patent App Pub No 20040102486 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
